©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1552-1567
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1552
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1552
Table 3 Summary of non Food and Drug Administration-approved multiplex assays that detect Clostridium difficile
| Assay | Company | Pathogens detected | Technology | Ref. |
| Gastrofinder Smart 17 Fast | PathoFinder | 9 bacteria, 4 viruses and 4 parasites | Multiplex Real-time PCR | [129] |
| EasyScreen Enteric assays | Genetic Signature | 7 bacteria, 8 viruses and 5 parasites | 3base Technology | [130] |
| RIDA®GENE | R-BioPharma AG | 11 bacteria, 4 viruses and 4 parasites | Multiplex Real-time PCR | [131] |
| FTD® Bacterial Gastroenteritis | Fast-Track Diagnostics | 9 bacteria, 5 viruses and 3 parasites | Multiplex Real-time PCR | [132] |
| CLART EnteroBac panel | Genomica | 19 bacteria | Low-density microarray | [133] |
| Faecal Bacteria | AusDiagnostics | 8 bacteria, 4 viruses and 3 parasites | Multiplex Tandem PCR technology | [134] |
| Seeplex Diarrhea ACE | Seegene | 10 bacteria and 4 viruses | Dual priming oligonucleotide technology | [135] |
- Citation: Martínez-Meléndez A, Camacho-Ortiz A, Morfin-Otero R, Maldonado-Garza HJ, Villarreal-Treviño L, Garza-González E. Current knowledge on the laboratory diagnosis of Clostridium difficile infection. World J Gastroenterol 2017; 23(9): 1552-1567
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1552.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1552